Adblue Injection
Zinc Sulfate Hydrate 22mg · Cupric Sulfate Hydrate 3.93mg +2 more
Injections · Prescription medication · Combination
Huons Co., Ltd.
MFDS item code 201500190 · Notified 2015.01.14
This product's status changed to Expired on 2025.01.14. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Prevention of trace element deficiencies during intravenous nutritional support
When providing intravenous nutrition, it is important to supply necessary trace elements to balance the trace elements in the body. Trace elements play essential roles in various physiological functions in our body, so they should be supplied appropriately to avoid deficiencies. This helps to maintain normal body function and improve nutritional status. Therefore, supply of trace elements during intravenous nutrition therapy assists in the recovery of the patient's health.
Permitted dosage range (for intravenous use) Use as prescribed by a physician, checking plasma trace element levels to guide dose adjustment. Patients receiving metabolically stable parenteral nutrition Zinc: 2.5~4㎎ daily Copper: 0.5~1.5㎎ daily Manganese: 0.15~0.8㎎ daily Chromium: 10~15㎍ daily Patients with small intestinal fluid losses Zinc: an additional 12.2mg/L (small intestinal fluid loss) or 17.1mg/kg (stool output) Copper: 20㎍ daily Patients in an acute catabolic state Zinc: 4.5~6mg daily
Pediatric patients -5 years of age or younger: Zinc 100㎍/kg of body weight daily; copper 20㎍/kg of body weight daily; manganese 2~10㎍/kg of body weight daily; chromium 0.14~0.20㎍/kg of body weight daily Pediatric patients - premature infants weighing 3kg or less: Zinc 300㎍/kg of body weight daily; copper 20㎍/kg of body weight daily; manganese 2~10㎍/kg of body weight daily; chromium 0.14~0.20㎍/kg of body weight daily
This medication should be diluted before administration, as injecting it directly into the vein without dilution may cause inflammation. This medication is a hypotonic solution and should only be used when mixed with other medications for injection. If any toxic reactions to any component occur during the use of this drug, administration should be discontinued immediately. The amounts of zinc, copper, manganese, and chromium in this drug are very small, so toxic symptoms are unlikely to occur at typical prescribing doses. Prior to administration, the physician must carefully assess the patient's health status and the amount needed by the body. Zinc is primarily excreted through the kidneys, so patients with poor kidney function may accumulate zinc in the body. Copper and manganese are excreted through bile, thus patients with blocked bile flow are at risk of accumulation of these components. Manganese is also excreted through pancreatic juice and can be reabsorbed in various parts of the small intestine. Chromium may affect blood sugar control, so diabetic patients should check their blood sugar status and the diabetes medications they are taking when using this drug. The safety of this drug during pregnancy is not well established, so women who are pregnant or may become pregnant should only use it after consulting a physician and when the benefits of treatment outweigh the risks. In cases of overdose, zinc may cause symptoms such as nausea, vomiting, dehydration, electrolyte imbalance, dizziness, abdominal pain, drowsiness, motor coordination disorders, and in severe cases, may result in death. Copper overdose may lead to symptoms like hypotension, behavioral changes, diarrhea, weight loss, muscle tension reduction, photophobia, and edema, with D-penicillamine being used as an antidote. Information on manganese overdose toxicity is limited, and toxicity from ingestion through food or drink has not been reported. Chromium overdose may lead to nausea, vomiting, ulcers, kidney and liver dysfunction, convulsions, and coma, which are central nervous system disorders. This drug must be used strictly according to a physician's prescription and should not be used arbitrarily without a prescription. When adding this drug to non-oral nutritional solutions, it is advisable to handle it carefully in a laminar flow cabinet to maintain aseptic conditions.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air and moisture from entering and should be kept at a temperature between 1 and 30 degrees Celsius (33.8 to 86 degrees Fahrenheit). Storing it this way will help maintain the drug's effectiveness.
A light blue transparent liquid contained in a colorless transparent vial.
2mL X 10 vials
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Zinc Sulfate Hydrate 22mg · Cupric Sulfate Hydrate 3.93mg +2 more
Injections · Prescription medication · Combination
Huons Co., Ltd.
Zinc Sulfate Hydrate 22mg · Cupric Sulfate Hydrate 3.93mg +2 more
Injections · Prescription medication · Combination
Green Cross Wellbeing Co., Ltd.
Zinc Sulfate Hydrate 22mg · Cupric Sulfate Hydrate 3.93mg +2 more
Injections · Prescription medication · Combination
Hanol Bio Pharma Co., Ltd.
Zinc Sulfate Hydrate · Cupric Sulfate Hydrate +2 more
Prescription medication · Combination
Donggu Biopharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.